iNKT cells in microbial immunity: Recognition of microbial glycolipids

Microbiology and Immunology

Volumn 55, Issue 7, 2011, Pages 472-482

  Kinjo, Yuki ^a   Ueno, Keigo ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Antigen; CD1d; Glycolipid; iNKT cell

Indexed keywords

CD11B ANTIGEN; CD1D ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; CD68 ANTIGEN; DIACYLGLYCEROL; GAMMA INTERFERON; GLYCOLIPID; GLYCOSPHINGOLIPID; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 18; MACROPHAGE INFLAMMATORY PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; ANTIGEN STRUCTURE; ANTIMICROBIAL ACTIVITY; ARTHRITIS; AUTOIMMUNE DISEASE; BACTERIAL INFECTION; BACTERIAL PNEUMONIA; CHLAMYDOPHILA INFECTION; CRYPTOCOCCOSIS; CYTOKINE PRODUCTION; ENDOCARDITIS; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOPATHOGENESIS; IMMUNOSTIMULATION; INFLAMMATION; INNATE IMMUNITY; LYME DISEASE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; MICROBIAL IMMUNITY; NATURAL KILLER CELL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PNEUMOCOCCAL INFECTION; PROTEIN PROTEIN INTERACTION; REVIEW;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, BACTERIAL; ANTIGENS, FUNGAL; ANTIGENS, PROTOZOAN; CYTOKINES; GLYCOLIPIDS; HUMANS; LYMPHOCYTE ACTIVATION; NATURAL KILLER T-CELLS;

EID: 79959765215     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2011.00338.x     Document Type: Review

References (81)

1. Taniguchi M., Harada M., Kojo S., Nakayama T., Wakao H. (2003) The regulatory role of Valpha14 NKT cells in innate and acquired immune response. Annu Rev Immunol 21: 483-513.
2. Brigl M., Brenner M.B. (2004) CD1: Antigen presentation and T cell function. Annu Rev Immunol 22: 817-90.
3. Godfrey D.I., Berzins S.P. (2007) Control points in NKT-cell development. Nat Rev Immunol 7: 505-18.
4. Tupin E., Kinjo Y., Kronenberg M. (2007) The unique role of natural killer T cells in the response to microorganisms. Nat Rev Microbiol 5: 405-17.
5. Sugita M., Cernadas M., Brenner M.B. (2004) New insights into pathways for CD1-mediated antigen presentation. Curr Opin Immunol 16: 90-5.
6. Young D.C., Moody D.B. (2006) T-cell recognition of glycolipids presented by CD1 proteins. Glycobiology 16: 103R-12R.
7. Zajonc D.M., Kronenberg M. (2007) CD1 mediated T cell recognition of glycolipids. Curr Opin Struct Biol 17: 521-9.
8. De Libero G., Collmann A., Mori L. (2009) The cellular and biochemical rules of lipid antigen presentation. Eur J Immunol 39: 2648-56.
9. Skold M., Behar S.M. (2003) Role of CD1d-restricted NKT cells in microbial immunity. Infect Immun 71: 5447-55.
10. Yu K.O., Porcelli S.A. (2005) The diverse functions of CD1d-restricted NKT cells and their potential for immunotherapy. Immunol Lett 100: 42-55.
11. Kawakami K., Yamamoto N., Kinjo Y., Miyagi K., Nakasone C., Uezu K., Kinjo T., Nakayama T., Taniguchi M., Saito A. (2003) Critical role of Valpha14+ natural killer T cells in the innate phase of host protection against Streptococcus pneumoniae infection. Eur J Immunol 33: 3322-30.
12. Cui J., Shin T., Kawano T., Sato H., Kondo E., Toura I., Kaneko Y., Koseki H., Kanno M., Taniguchi M. (1997) Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. Science 278: 1623-6.
13. Nakamatsu M., Yamamoto N., Hatta M., Nakasone C., Kinjo T., Miyagi K., Uezu K., Nakamura K., Nakayama T., Taniguchi M., Iwakura Y., Kaku M., Fujita J., Kawakami K. (2007) Role of interferon-gamma in Valpha14+ natural killer T cell-mediated host defense against Streptococcus pneumoniae infection in murine lungs. Microbes Infect 9: 364-74.
14. Sada-Ovalle I., Chiba A., Gonzales A., Brenner M.B., Behar S.M. (2008) Innate invariant NKT cells recognize Mycobacterium tuberculosis-infected macrophages, produce interferon-gamma, and kill intracellular bacteria. PLoS Pathog 4: e1000239.
15. Chen Y.H., Chiu N.M., Mandal M., Wang N., Wang C.R. (1997) Impaired NK1+ T cell development and early IL-4 production in CD1-deficient mice. Immunity 6: 459-67.
16. Smiley S.T., Kaplan M.H., Grusby M.J. (1997) Immunoglobulin E production in the absence of interleukin-4-secreting CD1-dependent cells. Science 275: 977-9.
17. Mendiratta S.K., Martin W.D., Hong S., Boesteanu A., Joyce S., Van Kaer L. (1997) CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4. Immunity 6: 469-77.
18. Behar S.M., Dascher C.C., Grusby M.J., Wang C.R., Brenner M.B. (1999) Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis. J Exp Med 189: 1973-80.
19. Sousa A.O., Mazzaccaro R.J., Russell R.G., Lee F.K., Turner O.C., Hong S., Van Kaer L., Bloom B.R. (2000) Relative contributions of distinct MHC class I-dependent cell populations in protection to tuberculosis infection in mice. Proc Natl Acad Sci U S A 97: 4204-8.
20. Sugawara I., Yamada H., Mizuno S., Li C.Y., Nakayama T., Taniguchi M. (2002) Mycobacterial infection in natural killer T cell knockout mice. Tuberculosis (Edinb) 82: 97-104.
21. Kawakami K., Kinjo Y., Uezu K., Yara S., Miyagi K., Koguchi Y., Nakayama T., Taniguchi M., Saito A. (2002) Minimal contribution of Valpha14 natural killer T cells to Th1 response and host resistance against mycobacterial infection in mice. Microbiol Immunol 46: 207-10.
22. Gansert J.L., Kiessler V., Engele M., Wittke F., Rollinghoff M., Krensky A.M., Porcelli S.A., Modlin R.L., Stenger S. (2003) Human NKT cells express granulysin and exhibit antimycobacterial activity. J Immunol 170: 3154-61.
23. Kawakami K., Kinjo Y., Uezu K., Yara S., Miyagi K., Koguchi Y., Nakayama T., Taniguchi M., Saito A. (2001) Monocyte chemoattractant protein-1-dependent increase of V alpha 14 NKT cells in lungs and their roles in Th1 response and host defense in cryptococcal infection. J Immunol 167: 6525-32.
24. Joyee A.G., Qiu H., Wang S., Fan Y., Bilenki L., Yang X. (2007) Distinct NKT cell subsets are induced by different Chlamydia species leading to differential adaptive immunity and host resistance to the infections. J Immunol 178: 1048-58.
25. Joyee A.G., Qiu H., Fan Y., Wang S., Yang X. (2008) Natural killer T cells are critical for dendritic cells to induce immunity in Chlamydial pneumonia. Am J Respir Crit Care Med 178: 745-56.
26. Joyee A.G., Uzonna J., Yang X. (2010) Invariant NKT cells preferentially modulate the function of CD8 alpha+ dendritic cell subset in inducing type 1 immunity against infection. J Immunol 184: 2095-106.
27. De Santo C., Salio M., Masri S.H., Lee L.Y., Dong T., Speak A.O., Porubsky S., Booth S., Veerapen N., Besra G.S., Grone H.J., Platt F.M., Zambon M., Cerundolo V. (2008) Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humans. J Clin Invest 118: 4036-48.
28. Kim E.Y., Battaile J.T., Patel A.C., You Y., Agapov E., Grayson M.H., Benoit L.A., Byers D.E., Alevy Y., Tucker J., Swanson S., Tidwell R., Tyner J.W., Morton J.D., Castro M., Polineni D., Patterson G.A., Schwendener R.A., Allard J.D., Peltz G., Holtzman M.J. (2008) Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease. Nat Med 14: 633-40.
29. Brigl M., Bry L., Kent S.C., Gumperz J.E., Brenner M.B. (2003) Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat Immunol 4: 1230-7.
30. Nagarajan N.A., Kronenberg M. (2007) Invariant NKT cells amplify the innate immune response to lipopolysaccharide. J Immunol 178: 2706-13.
31. Wesley J.D., Tessmer M.S., Chaukos D., Brossay L. (2008) NK cell-like behavior of Valpha14i NK T cells during MCMV infection. PLoS Pathog 4: e1000106.
32. Tyznik A.J., Tupin E., Nagarajan N.A., Her M.J., Benedict C.A., Kronenberg M. (2008) Cutting edge: the mechanism of invariant NKT cell responses to viral danger signals. J Immunol 181: 4452-6.
33. Paget C., Bialecki E., Fontaine J., Vendeville C., Mallevaey T., Faveeuw C., Trottein F. (2009) Role of invariant NK T lymphocytes in immune responses to CpG oligodeoxynucleotides. J Immunol 182: 1846-53.
34. Ishigami M., Nishimura H., Naiki Y., Yoshioka K., Kawano T., Tanaka Y., Taniguchi M., Kakumu S., Yoshikai Y. (1999) The roles of intrahepatic Valpha14(+) NK1.1(+) T cells for liver injury induced by Salmonella infection in mice. Hepatology 29: 1799-808.
35. Berntman E., Rolf J., Johansson C., Anderson P., Cardell S.L. (2005) The role of CD1d-restricted NK T lymphocytes in the immune response to oral infection with Salmonella typhimurium. Eur J Immunol 35: 2100-9.
36. Kawano T., Cui J., Koezuka Y., Toura I., Kaneko Y., Motoki K., Ueno H., Nakagawa R., Sato H., Kondo E., Koseki H., Taniguchi M. (1997) CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science 278: 1626-9.
37. Kobayashi E., Motoki K., Uchida T., Fukushima H., Koezuka Y. (1995) KRN7000, a novel immunomodulator, and its antitumor activities. Oncol Res 7: 529-34.
38. Morita M., Motoki K., Akimoto K., Natori T., Sakai T., Sawa E., Yamaji K., Koezuka Y., Kobayashi E., Fukushima H. (1995) Structure-activity relationship of alpha-galactosylceramides against B16-bearing mice. J Med Chem 38: 2176-87.
39. Fischer K., Scotet E., Niemeyer M., Koebernick H., Zerrahn J., Maillet S., Hurwitz R., Kursar M., Bonneville M., Kaufmann S.H., Schaible U.E. (2004) Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells. Proc Natl Acad Sci U S A 101: 10685-90.
40. Amprey J.L., Im J.S., Turco S.J., Murray H.W., Illarionov P.A., Besra G.S., Porcelli S.A., Spath G.F. (2004) A subset of liver NK T cells is activated during Leishmania donovani infection by CD1d-bound lipophosphoglycan. J Exp Med 200: 895-904.
41. Kinjo Y., Wu D., Kim G., Xing G.W., Poles M.A., Ho D.D., Tsuji M., Kawahara K., Wong C.H., Kronenberg M. (2005) Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 434: 520-5.
42. Mattner J., Debord K.L., Ismail N., Goff R.D., Cantu C., 3rd, Zhou D., Saint-Mezard P., Wang V., Gao Y., Yin N., Hoebe K., Schneewind O., Walker D., Beutler B., Teyton L., Savage P.B., Bendelac A. (2005) Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434: 525-9.
43. Sriram V., Du W., Gervay-Hague J., Brutkiewicz R.R. (2005) Cell wall glycosphingolipids of Sphingomonas paucimobilis are CD1d-specific ligands for NKT cells. Eur J Immunol 35: 1692-701.
44. Neef A., Witzenberger R., Kampfer P. (1999) Detection of sphingomonads and in situ identification in activated sludge using 16S rRNA-targeted oligonucleotide probes. J Ind Microbiol Biotechnol 23: 261-7.
45. Selmi C., Balkwill D.L., Invernizzi P., Ansari A.A., Coppel R.L., Podda M., Leung P.S., Kenny T.P., Van De Water J., Nantz M.H., Kurth M.J., Gershwin M.E. (2003) Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium. Hepatology 38: 1250-7.
46. Kawahara K., Moll H., Knirel Y.A., Seydel U., Zahringer U. (2000) Structural analysis of two glycosphingolipids from the lipopolysaccharide-lacking bacterium Sphingomonas capsulata. Eur J Biochem 267: 1837-46.
47. Kawahara K., Kubota M., Sato N., Tsuge K., Seto Y. (2002) Occurrence of an alpha-galacturonosyl-ceramide in the dioxin-degrading bacterium Sphingomonas wittichii. FEMS Microbiol Lett 214: 289-94.
48. Kawahara K., Sato N., Tsuge K., Seto Y. (2006) Confirmation of the anomeric structure of galacturonic acid in the galacturonosyl-ceramide of Sphingomonas yanoikuyae. Microbiol Immunol 50: 67-71.
49. Kinjo Y., Tupin E., Wu D., Fujio M., Garcia-Navarro R., Benhnia M.R., Zajonc D.M., Ben-Menachem G., Ainge G.D., Painter G.F., Khurana A., Hoebe K., Behar S.M., Beutler B., Wilson I.A., Tsuji M., Sellati T.J., Wong C.H., Kronenberg M. (2006) Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nat Immunol 7: 978-86.
50. Ben-Menachem G., Kubler-Kielb J., Coxon B., Yergey A., Schneerson R. (2003) A newly discovered cholesteryl galactoside from Borrelia burgdorferi. Proc Natl Acad Sci U S A 100: 7913-8.
51. Wang J., Li Y., Kinjo Y., Mac T.-T., Gibson D., Painter G., Kronenberg M., Zajonc D. (2010) Lipid binding orientation within CD1d affects recognition of Borrelia burgorferi antigens by NKT cells. Proc Natl Acad Sci U S A 107: 1535-40.
52. Wu D., Zajonc D.M., Fujio M., Sullivan B.A., Kinjo Y., Kronenberg M., Wilson I.A., Wong C.H. (2006) Design of natural killer T cell activators: Structure and function of a microbial glycosphingolipid bound to mouse CD1d. Proc Natl Acad Sci U S A 103: 3972-7.
53. Li Y., Girardi E., Wang J., Yu E.D., Painter G.F., Kronenberg M., Zajonc D.M. (2010) The Valpha14 invariant natural killer T cell TCR forces microbial glycolipids and CD1d into a conserved binding mode. J Exp Med 207: 2383-93.
54. Kumar H., Belperron A., Barthold S.W., Bockenstedt L.K. (2000) Cutting edge: CD1d deficiency impairs murine host defense against the spirochete, Borrelia burgdorferi. J Immunol 165: 4797-801.
55. Colgan S.P., Hershberg R.M., Furuta G.T., Blumberg R.S. (1999) Ligation of intestinal epithelial CD1d induces bioactive IL-10: critical role of the cytoplasmic tail in autocrine signaling. Proc Natl Acad Sci U S A 96: 13, 938-43.
56. Yue S.C., Shaulov A., Wang R., Balk S.P., Exley M.A. (2005) CD1d ligation on human monocytes directly signals rapid NF-kappaB activation and production of bioactive IL-12. Proc Natl Acad Sci U S A 102: 11, 811-6.
57. Tupin E., Benhnia M.R., Kinjo Y., Patsey R., Lena C.J., Haller M.C., Caimano M.J., Imamura M., Wong C.H., Crotty S., Radolf J.D., Sellati T.J., Kronenberg M. (2008) NKT cells prevent chronic joint inflammation after infection with Borrelia burgdorferi. Proc Natl Acad Sci U S A 105: 19863-8.
58. Olson C.M., Jr., Bates T.C., Izadi H., Radolf J.D., Huber S.A., Boyson J.E., Anguita J. (2009) Local production of IFN-gamma by invariant NKT cells modulates acute Lyme carditis. J Immunol 182: 3728-34.
59. Mattner J., Savage P.B., Leung P., Oertelt S.S., Wang V., Trivedi O., Scanlon S.T., Pendem K., Teyton L., Hart J., Ridgway W.M., Wicker L.S., Gershwin M.E., Bendelac A. (2008) Liver autoimmunity triggered by microbial activation of natural killer T cells. Cell Host Microbe 3: 304-15.
60. Nieuwenhuis E.E., Matsumoto T., Exley M., Schleipman R.A., Glickman J., Bailey D.T., Corazza N., Colgan S.P., Onderdonk A.B., Blumberg R.S. (2002) CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung. Nat Med 8: 588-93.
61. Minagawa S., Ohyama C., Hatakeyama S., Tsuchiya N., Kato T., Habuchi T. (2005) Activation of natural killer T cells by alpha-galactosylceramide mediates clearance of bacteria in murine urinary tract infection. J Urol 173: 2171-4.
62. Kawakami K., Kinjo Y., Yara S., Koguchi Y., Uezu K., Nakayama T., Taniguchi M., Saito A. (2001) Activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide results in development of Th1 response and local host resistance in mice infected with Cryptococcus neoformans. Infect Immun 69: 213-20.
63. Emoto M., Yoshida T., Fukuda T., Kawamura I., Mitsuyama M., Kita E., Hurwitz R., Kaufmann S.H., Emoto Y. (2010) Alpha-galactosylceramide promotes killing of Listeria monocytogenes within the macrophage phagosome through invariant NKT-cell activation. Infect Immun 78: 2667-76.
64. Chackerian A., Alt J., Perera V., Behar S.M. (2002) Activation of NKT cells protects mice from tuberculosis. Infect Immun 70: 6302-9.
65. Sada-Ovalle I., Skold M., Tian T., Besra G.S., Behar S.M. (2010) Alpha-galactosylceramide as a therapeutic agent for pulmonary Mycobacterium tuberculosis infection. Am J Respir Crit Care Med 182: 841-7.
66. Zhou D., Mattner J., Cantu C., 3rd, Schrantz N., Yin N., Gao Y., Sagiv Y., Hudspeth K., Wu Y.P., Yamashita T., Teneberg S., Wang D., Proia R.L., Levery S.B., Savage P.B., Teyton L., Bendelac A. (2004) Lysosomal glycosphingolipid recognition by NKT cells. Science 306: 1786-9.
67. Speak A.O., Salio M., Neville D.C., Fontaine J., Priestman D.A., Platt N., Heare T., Butters T.D., Dwek R.A., Trottein F., Exley M.A., Cerundolo V., Platt F.M. (2007) Implications for invariant natural killer T cell ligands due to the restricted presence of isoglobotrihexosylceramide in mammals. Proc Natl Acad Sci U S A 104: 5971-6.
68. Porubsky S., Speak A.O., Luckow B., Cerundolo V., Platt F.M., Grone H.J. (2007) Normal development and function of invariant natural killer T cells in mice with isoglobotrihexosylceramide (iGb3) deficiency. Proc Natl Acad Sci U S A 104: 5977-82.
69. Christiansen D., Milland J., Mouhtouris E., Vaughan H., Pellicci D.G., Mcconville M.J., Godfrey D.I., Sandrin M.S. (2008) Humans lack iGb3 due to the absence of functional iGb3-synthase: implications for NKT cell development and transplantation. PLoS Biol 6: e172.
70. Ko S.Y., Ko H.J., Chang W.S., Park S.H., Kweon M.N., Kang C.Y. (2005) alpha-Galactosylceramide can act as a nasal vaccine adjuvant inducing protective immune responses against viral infection and tumor. J Immunol 175: 3309-17.
71. Youn H.J., Ko S.Y., Lee K.A., Ko H.J., Lee Y.S., Fujihashi K., Boyaka P.N., Kim S.H., Horimoto T., Kweon M.N., Kang C.Y. (2007) A single intranasal immunization with inactivated influenza virus and alpha-galactosylceramide induces long-term protective immunity without redirecting antigen to the central nervous system. Vaccine 25: 5189-98.
72. Kamijuku H., Nagata Y., Jiang X., Ichinohe T., Tashiro T., Mori K., Taniguchi M., Hase K., Ohno H., Shimaoka T., Yonehara S., Odagiri T., Tashiro M., Sata T., Hasegawa H., Seino K.I. (2008) Mechanism of NKT cell activation by intranasal co-administration of alpha-galactosylceramide, which can induce cross-protection against influenza viruses. Mucosal Immunol 1: 208-18.
73. Guillonneau C., Mintern J.D., Hubert F.X., Hurt A.C., Besra G.S., Porcelli S., Barr I.G., Doherty P.C., Godfrey D.I., Turner S.J. (2009) Combined NKT cell activation and influenza virus vaccination boosts memory CTL generation and protective immunity. Proc Natl Acad Sci U S A 106: 3330-5.
74. Kopecky-Bromberg S.A., Fraser K.A., Pica N., Carnero E., Moran T.M., Franck R.W., Tsuji M., Palese P. (2009) Alpha-C-galactosylceramide as an adjuvant for a live attenuated influenza virus vaccine. Vaccine 27: 3766-74.
75. Gonzalez-Aseguinolaza G., Van Kaer L., Bergmann C.C., Wilson J.M., Schmieg J., Kronenberg M., Nakayama T., Taniguchi M., Koezuka Y., Tsuji M. (2002) Natural killer T cell ligand alpha-galactosylceramide enhances protective immunity induced by malaria vaccines. J Exp Med 195: 617-24.
76. Li X., Fujio M., Imamura M., Wu D., Vasan S., Wong C.H., Ho D.D., Tsuji M. (2010) Design of a potent CD1d-binding NKT cell ligand as a vaccine adjuvant. Proc Natl Acad Sci U S A 107: 13010-5.
77. Huang Y., Chen A., Li X., Chen Z., Zhang W., Song Y., Gurner D., Gardiner D., Basu S., Ho D.D., Tsuji M. (2008) Enhancement of HIV DNA vaccine immunogenicity by the NKT cell ligand, alpha-galactosylceramide. Vaccine 26: 1807-16.
78. Courtney A.N., Nehete P.N., Nehete B.P., Thapa P., Zhou D., Sastry K.J. (2009) Alpha-galactosylceramide is an effective mucosal adjuvant for repeated intranasal or oral delivery of HIV peptide antigens. Vaccine 27: 3335-41.
79. Lindqvist M., Persson J., Thorn K., Harandi A.M. (2009) The mucosal adjuvant effect of alpha-galactosylceramide for induction of protective immunity to sexually transmitted viral infection. J Immunol 182: 6435-43.
80. Motohashi S., Nagato K., Kunii N., Yamamoto H., Yamasaki K., Okita K., Hanaoka H., Shimizu N., Suzuki M., Yoshino I., Taniguchi M., Fujisawa T., Nakayama T. (2009) A phase I-II study of alpha-galactosylceramide-pulsed IL-2/GM-CSF-cultured peripheral blood mononuclear cells in patients with advanced and recurrent non-small cell lung cancer. J Immunol 182: 2492-501.
81. Kunii N., Horiguchi S., Motohashi S., Yamamoto H., Ueno N., Yamamoto S., Sakurai D., Taniguchi M., Nakayama T., Okamoto Y. (2009) Combination therapy of in vitro-expanded natural killer T cells and alpha-galactosylceramide-pulsed antigen-presenting cells in patients with recurrent head and neck carcinoma. Cancer Sci 100: 1092-8.